← back to search

Angelos G. Rigopoulos

Mitera Hospital ·
Area of research
Cardiology and Cardiovascular Medicine
Research interest
Research interests include Cardiomyopathy and Myosin Studies, Cardiovascular Effects of Exercise, Cardiovascular Function and Risk Factors, and Viral Infections and Immunology Research.
h-index
25
citations
8,030
works
122
NIH funding
primary concept
Medicine
email

Recent publications

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
European Heart Journal 2021cited by 1,126position: middledoi
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology <scp>W</scp> orking <scp>G</scp> roup on <scp>M</scp> yocardial and <scp>P</scp> ericardial <scp>D</scp> iseases
European Journal of Heart Failure 2021cited by 327position: middledoi
Atrial Fibrillation, Anticoagulation Management and Risk of Stroke in the Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of Cardiology
ESC Heart Failure 2020cited by 27position: middledoi
Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease
European Heart Journal 2017cited by 262position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Alida L.P. Caforio · Fondation pour l’innovation en Cadiométabolisme et Nutrition3 papers (2020–2021)Antonio Brucato · Misericordia University2 papers (2021–2021)Claudio Rapezzi · Fondazione Toscana Gabriele Monasterio2 papers (2021–2021)Urs Eriksson · University of Zurich2 papers (2021–2021)Ingrid Kindermann · Universitätsklinikum des Saarlandes2 papers (2021–2021)Michael Arad · Bristol-Myers Squibb (United States)2 papers (2021–2021)Sabine Pankuweit · Philips (Germany)2 papers (2021–2021)Marianna Fontana · Johnson & Johnson (United States)2 papers (2021–2021)Massimo Imazio · Istituti di Ricovero e Cura a Carattere Scientifico2 papers (2021–2021)Julian D. Gillmore · Alnylam Pharmaceuticals (United States)2 papers (2021–2021)Matthew J. Maurer · Toyota Motor Corporation (Switzerland)2 papers (2021–2021)Pablo García‐Pavía · Hospital La Paz Institute for Health Research2 papers (2021–2021)Stéphane Heymans · Maastricht University Medical Centre2 papers (2021–2021)Yehuda Adler · Tel Aviv University2 papers (2021–2021)Arnt V. Kristen · Heidelberg University2 papers (2021–2021)Thibaud Damy · BNP Paribas (France)2 papers (2021–2021)Martha Grogan · Mayo Clinic2 papers (2021–2021)Aleš Linhart · University Hospital in Motol2 papers (2021–2021)Esther González-López · Light Prescriptions Innovators (Spain)2 papers (2021–2021)Giampaolo Merlini · Amyloidosis Foundation2 papers (2021–2021)